Skip to main content
Log in

Adalimumab/etanercept

Demyelinating disease: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Andreadou E, Kemanetzoglou E, Sfakianaki K, Evangelopoulos ME, Rombos A, Stamboulis E.Demyelinating disease following anti-TNF-alpha treatment: A causal or coincidental association? Report of two cases. 16th Congress of the European Federation of Neurological Societies: abstr. P2732, 8 Sep 2012. Available from: URL: http://www.efns.org - Greece

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adalimumab/etanercept. React. Wkly. 1423, 5 (2012). https://doi.org/10.2165/00128415-201214230-00015

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214230-00015

Keywords

Navigation